Characterization of membrane protein complex associated with dystrophin
Characterization of membrane protein complex associated with dystrophin
批准号:
06454280
负责人:
SHIMIZU Teruo
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In the present study, we have investigated the biological functions of the dystroglycan complex in the nervous system. As results, we show that the nervous system alpha-dystroglycan has a molecular mass of 120 kDa instead of 15kDa of that of muscle. The nervous system alpha-dystroglycan binds laminin with high affinity and this binding is dependent on calcium and is inhibited by heparin and NaCl. The nervous system alpha-dystroglycan is presumed to be associated with Dp116 and utrophin as anchoring proteins, but not the sarcoglycan complex. We also show that 120 kDa alpha-dystroglycan is a Schwann cell receptor of laminin-2, the endoneurial isoform of laminin comprised of the alpha2, beta1 and gamma1 chains, in the peripheral nervous system. Schwann cellalpha-dystroglycan is also a receptor of agrin, an acetylcholine receptor-aggregating molecule having partial homology to laminin alpha chains in the C-terminus. Immunochemical analysis demonstrates that the peripheral nerve isoform of agrin is a 400 kDa component of the endoneurial basal lamina and is co-localized with alpha-dystroglycan surrounding the outermost layr of myelin sheath of peripheral nerve fibers. Blot overlay analysis demonstrates that both endogenous peripheral nerve agrin and laminin-2 bind to Schwann cell alpha-dystroglycan. Recombinant C-terminal fragment of the peripheral nerve isoform of agrin also binds to Schwann cell alpha-dystroglycan, confirming that the binding site for Schwann cell alpha-dystroglycan resides in the C-terminus of agrinmolecule. Furthermore, the binding of recombinant agrin C-terminal fragment to Schwann cell alpha-dystroglycan competes with that of laminin-2. All together, these results indicate that alpha-dystroglycan is a dual receptor for agrin and laminin-2 in the Schwann cell membrane. Currently, we are investigating the biological functions of the dystroglycan complex in the central nervous system.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yamada H et al.: "Dystroglycan is a dual receptor for agrin and laminin in Schwann......" Journal of Biological Chemistry. 271. 23418-23423 (1996)
Yamada H 等人:“Dystroglycan 是 Schwann 中集聚蛋白和层粘连蛋白的双重受体......”《生物化学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawai H et al.: "Adhalin gene mutations in patients with autosomal recessive......" Journal of Clinical Investigation. 96. 1202-1207 (1995)
Kawai H 等人:“常染色体隐性遗传患者的 Adhalin 基因突变......”临床研究杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamada, H., Tome, F.M.S., Higuchi, I., Kawai, H., Azibi, K., chaouch, M., Roberds, S.L., Tanaka, T., Fujita, S., Mitusi, T., Fukunaga, H., Miyoshi, K., Osame, M., Fardeau, M., Kaplan, J-C., Shimizu, T., Campbell, K.P., and Matsumura, K.: "Laminin abnormal
山田,H.,登米,F.M.S.,樋口,I.,河合,H.,阿兹比,K.,chaouch,M.,罗伯兹,S.L.,田中,T.,藤田,S.,三井,T.,福永,
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higuchi, I., Yamada, H., Fukunaga, H., Iwaki, H., Okubo, R., Nakagawa, M., Osame, M., Roberds, S.L., Shimizu, T., Campbell, K.P., and Matsumura, K.: "Abnormal expression of laminin suggests disturbance of sarcolemma-extracellular matrix interaction in Jap
樋口,I.,山田,H.,福永,H.,岩木,H.,大久保,R.,中川,M.,奥萨梅,M.,罗伯兹,S.L.,清水,T.,坎贝尔,K.P.和松村
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
蔡偉超ら: "原発生胆汁性肝硬変と心筋障害を合併しdystrophinカルボキシル......" 臨床神経. 36. 876-880 (1996)
蔡伟超等:“肌营养不良蛋白羧酸与原发性胆汁性肝硬化和心肌损伤相关......”临床神经病学 36. 876-880 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Development of novel cancer therapy by functional up-regulation of dystroglycan using glycosyltransferase LARGE
-
批准号:24501357
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2012
-
负责人:SHIMIZU Teruo
-
依托单位:
Molecular pathogenesis of congenital muscular dystrophies and development of new therapeutic measures
-
批准号:16390256
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.76万
-
财政年份:2004
-
负责人:SHIMIZU Teruo
-
依托单位:
Musecle cell dysfunction caused by disturbed cell adhesion and signal transduction
-
批准号:12470143
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2000
-
负责人:SHIMIZU Teruo
-
依托单位:
Production of muscular dystrophy mice by molecular engineering
-
批准号:09470156
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.38万
-
财政年份:1997
-
负责人:SHIMIZU Teruo
-
依托单位:
Immunochemical analysis of DMD gene product dystrophin
-
批准号:01480238
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1989
-
负责人:SHIMIZU Teruo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胃癌间质干细胞分泌lamininγ2调控PD-L1的机制研究及其在免疫治疗反应性预测中的作用
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:孙丽
-
依托单位:
用组织工程皮肤模型研究laminin诱导人羊膜上皮细胞向表皮细胞分化及其机制
-
批准号:82160601
-
项目类别:地区科学基金项目
-
资助金额:35万元
-
批准年份:2021
-
负责人:江蕾微
-
依托单位:
Laminin-332/PCDH7通路促进胰腺癌的作用和机制研究
-
批准号:82172931
-
项目类别:面上项目
-
资助金额:54.7万元
-
批准年份:2021
-
负责人:丁晓凌
-
依托单位:
应用类器官芯片研究Laminin在USH2A突变型视网膜色素变性发病中的作用及机制
-
批准号:82000943
-
项目类别:青年科学基金项目
-
资助金额:16.0万元
-
批准年份:2020
-
负责人:郭永龙
-
依托单位:
laminin/Integrin相互作用调节蛛网膜下腔出血后脑血管重塑的作用及机制研究
-
批准号:81801137
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张洪荣
-
依托单位:
Laminin 5γ2在食管鳞癌转移、复发中的作用及其分子机制研究
-
批准号:81802444
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:石超
-
依托单位:
FAM83A通过Laminin-Integrin调控PI3K/AKT通路影响宫颈癌侵袭转移的机制研究
-
批准号:81702552
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:许君芬
-
依托单位:
整合素α6β4/α3β1介导laminin α3基因涂层在种植体-牙龈生物学封闭形成中的作用及机制研究
-
批准号:81701021
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2017
-
负责人:张晶
-
依托单位:
Laminin和IGF协同介导非肝癌干细胞去分化的机制研究
-
批准号:81572464
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:单娟娟
-
依托单位:
电刺激调控神经干细胞在氧化铱/聚多巴胺/Laminin仿生涂层上的定向分化研究
-
批准号:51502265
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2015
-
负责人:陈岑
-
依托单位: